Ezetimibe BE [Regulatives / Guidelines]

posted by Mutasim – Jordan, 2019-09-23 16:40 (1840 d 20:56 ago) – Posting: # 20641
Views: 6,112

Dear Members,
Would you please advice on interpretation of the requirements for Ezetimibe BE according to the last guidance by EMA, in particular the statement
"Main pharmacokinetic variables: AUC0-72h, Cmax
Background/justification: On total (parent + glucuronide metabolite together)
Does it mean measuring each one alone? or the total as in FDA guidance? and accordingly will the CI be for each one alone or both unconjugated and total or only total?


Edit: Guideline linked. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,247 posts in 4,885 threads, 1,652 registered users;
76 visitors (0 registered, 76 guests [including 10 identified bots]).
Forum time: 13:36 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5